I agree that this site is using cookies. You can find further informations here.
X
Sundar, Raghav
193  results:
Search for persons X
?
1

FRailty in Australian patients admitted to Intensive care u..:

Ling, Ryan R. ; Ueno, Ryo ; Alamgeer, Muhammad...
British Journal of Anaesthesia.  132 (2024)  4 - p. 695-706 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Molecular profiling of metastatic breast cancer and target-..:

Walsh, Robert John ; Ong, Rebecca ; Cheo, Seng Wee...
Frontiers in Oncology.  14 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
3

Charting the path forward in Southeast Asia: Learning from ..:

Fu, Jolene Yin Ling ; Pukhari, Muhammad Harith ; Dela Cruz, Kristine Alvarado...
Journal of Global Health.  14 (2024)  - p. , 2024
Link: https://doi.org/10.7189/..
 
?
4

Efficacy and Safety of Trifluridine/Tipiracil-Containing Co..:

Shitara, Kohei ; Falcone, Alfred ; Fakih, Marwan G...
The Oncologist.  29 (2024)  5 - p. e601-e615 , 2024
Link: https://doi.org/10.1093/..
 
?
5

Inconsistencies in the predictive value of PD-L1 in metasta..:

Sundar, Raghav ; Smyth, Elizabeth C
The Lancet Gastroenterology & Hepatology.  9 (2024)  6 - p. 495-497 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Frailty and long-term survival among patients in Australian..:

Alamgeer, Muhammad ; Ling, Ryan Ruiyang ; Ueno, Ryo...
The Lancet Healthy Longevity.  4 (2023)  12 - p. e675-e684 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Phase II study of trifluridine/tipiracil in metastatic brea..:

Lim, Joline S.J. ; Ow, Samuel G.W. ; Wong, Andrea L.A....
European Journal of Cancer.  193 (2023)  - p. 113311 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Clinical efficacy and Long-term Immunogenicity of early tri..:

Li, Jiaqi ; Lee, Matilda ; Peng, Siyu...
European Journal of Surgical Oncology.  49 (2023)  2 - p. e60-e61 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Effects of prior therapies on outcomes with trifluridine/ti..:

Shitara, Kohei ; George, Ben ; Taieb, Julien...
Journal of Cancer Research and Clinical Oncology.  149 (2023)  11 - p. 9361-9374 , 2023
Link: https://doi.org/10.1007/..
 
?
10

Clinical outcome and prognostic factors for Asian patients ..:

Loh, Jerold ; Wu, Jiaxuan ; Chieng, Jenny...
British Journal of Cancer.  128 (2023)  8 - p. 1514-1520 , 2023
Link: https://doi.org/10.1038/..
 
?
11

A Phase I, First-in-Human Study of PRL3-zumab in Advanced, ..:

Chee, Cheng E. ; Ooi, Melissa ; Lee, Soo-Chin...
Targeted Oncology.  18 (2023)  3 - p. 391-402 , 2023
Link: https://doi.org/10.1007/..
 
?
12

Combining chemotherapy, trastuzumab, and immune-checkpoint ..:

Smyth, Elizabeth C ; Sundar, Raghav
The Lancet.  402 (2023)  10418 - p. 2168-2170 , 2023
Link: https://doi.org/10.1016/..
 
?
13

Immune checkpoint inhibitor combinations—current and emergi..:

Walsh, Robert J. ; Sundar, Raghav ; Lim, Joline S. J.
British Journal of Cancer.  128 (2023)  8 - p. 1415-1417 , 2023
Link: https://doi.org/10.1038/..
 
?
14

Spatiotemporal genomic profiling of intestinal metaplasia r..:

Huang, Kie Kyon ; Ma, Haoran ; Chong, Roxanne Hui Heng...
Cancer Cell.  41 (2023)  12 - p. 2019-2037.e8 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Indirect Treatment Comparison of First-Line CDK4/6-Inhibito..:

Zhao, Joseph J. ; Fong, Khi Yung ; Chan, Yiong Huak...
Cancers.  15 (2023)  18 - p. 4558 , 2023
Link: https://doi.org/10.3390/..
 
1-15